Loading clinical trials...
Loading clinical trials...
REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension
Conditions
Interventions
REN-1654
Locations
16
United States
North Alabama Neuroscience Research Associates
Huntsville, Alabama, United States
Pivotal Research Centers
Peoria, Arizona, United States
HOPE Research Institute
Phoenix, Arizona, United States
Advanced Clinical Therapeutics, LLC
Tuscon, Arizona, United States
UCSD Center for Pain and Palliative Medicine
La Jolla, California, United States
Neurophysiologic Laboratory
Laguna Hills, California, United States
Start Date
August 1, 2003
Completion Date
December 1, 2004
Last Updated
July 29, 2010
NCT04800484
NCT06398847
NCT04144972
NCT07000409
NCT06896994
NCT05152368
Lead Sponsor
Renovis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions